- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Her2
Total 2770 results
-
Herbert LyerlyMerck Sharp & Dohme LLCActive, not recruitingBreast Cancer | HER2+ Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedBreast CancerUnited States
-
Second Affiliated Hospital of Guangzhou Medical...Guangdong Zhaotai InVivo Biomedicine Co. Ltd.; Hunan Zhaotai Yongren Medical...RecruitingCancer | Lung Cancer | Immunotherapy | CAR-T CellChina
-
Henan Cancer HospitalRecruiting
-
SOLTI Breast Cancer Research GroupNovartis; Alliance Foundation Trials, LLC.RecruitingMetastatic Breast CancerUnited States, Spain, Portugal
-
Cancer Trials IrelandCompletedMetastatic Breast CancerSpain, Ireland, Israel, Finland, Portugal, France, Germany, Norway
-
Istituto Oncologico Veneto IRCCSUniversity of PadovaCompleted
-
PfizerCompletedCarcinoma, Non-small CellUnited States, Taiwan, Korea, Republic of, Japan, Hong Kong
-
AstraZenecaDaiichi Sankyo Co., Ltd.; Daiichi Sankyo Company, LimitedActive, not recruitingMetastatic Breast CancerBelgium, United States, Taiwan, Korea, Republic of, Brazil, Russian Federation, Canada, Australia, France, Mexico
-
Zhejiang Cancer HospitalProswell Medical CorporationRecruitingMetastatic Breast CancerChina
-
Ottawa Hospital Research InstituteUnknown
-
National Cancer Institute (NCI)WithdrawnAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic HER2-Negative Breast Carcinoma | Unresectable HER2-Negative Breast Carcinoma
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingBreast Adenocarcinoma | HER2-Positive Breast CarcinomaUnited States
-
Tomsk National Research Medical Center of the Russian...Uppsala UniversityCompletedFemale | HER2-positive Breast CancerRussian Federation
-
Astellas Pharma Global Development, Inc.Active, not recruitingLocally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer | Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer | Metastatic Gastric Adenocarcinoma or Cancer | Metastatic Gastroesophageal Junction (GEJ) AdenocarcinomaUnited States, Australia, Belgium, Brazil, Canada, Chile, China, Colombia, France, Germany, Israel, Italy, Japan, Korea, Republic of, Mexico, Peru, Poland, Spain, Taiwan, United Kingdom
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyRecruitingHER2-positive Advanced Gastric Cancer | HER2-positive Gastroesophageal Junction AdenocarcinomaAustria, Belgium, Germany, Italy
-
Novartis PharmaceuticalsRecruiting
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Not yet recruitingHER2-positive Advanced Breast Cancer
-
Beijing 302 HospitalNot yet recruitingHR+/HER2- Advanced Breast CancerChina
-
Peking University People's HospitalRecruitingHER2-negative Early Breast CancerChina
-
Peking University People's HospitalRecruitingHER2-positive Early Breast CancerChina
-
Institut CurieRecruitingHER2-negative Metastatic Breast CancerFrance
-
AstraZenecaActive, not recruitingER+ HER2- Advanced Breast CancerJapan
-
Hoffmann-La RocheActive, not recruiting
-
Liaoning Tumor Hospital & InstituteCompletedHER2-positive Metastatic Breast CancerChina
-
Memorial Sloan Kettering Cancer CenterHoffmann-La Roche; Genentech, Inc.; Hartford HealthCareActive, not recruitingMetastatic HER2-Positive Breast CancerUnited States
-
Shanghai Institute Of Biological ProductsFudan UniversityCompletedHER2-positive Early Breast CancerChina
-
Memorial Sloan Kettering Cancer CenterUnited States Department of DefenseActive, not recruitingBreast Cancer | Metastatic HER2-negative BreastUnited States
-
City of Hope Medical CenterGlaxoSmithKline; NovartisActive, not recruitingBreast Neoplasms | HER2/Neu Positive | Geriatric Health ServicesUnited States
-
Jiangsu HengRui Medicine Co., Ltd.UnknownHER2 Positive Metastatic Breast CancerChina
-
Seagen Inc.CompletedHER2 Positive Metastatic Breast CancersUnited States
-
Bio-Thera SolutionsUnknownHER2-positive Advanced Breast CancerChina
-
Gilead SciencesTerminatedAdvanced Estrogen Receptor Positive HER2- Breast CancerUnited States
-
AstraZenecaCompletedER+ HER2- Advanced Breast CancerUnited States, United Kingdom, Korea, Republic of
-
German Breast GroupBoehringer IngelheimCompleted
-
National Cancer Institute (NCI)CompletedStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | HER2/Neu PositiveUnited States, Puerto Rico
-
Shanghai Pharmaceuticals Holding Co., LtdCompletedMetastatic Breast Cancer | Recurrent Breast CancerChina
-
Consorzio OncotechClinical Research Technology S.r.l.UnknownMetastatic Breast CancerItaly
-
Ruijin HospitalActive, not recruitingPulmonary Metastases | Osteosarcoma | ApatinibChina
-
Eisai Co., Ltd.Active, not recruiting
-
Fuda Cancer Hospital, GuangzhouWithdrawn
-
Austrian Breast & Colorectal Cancer Study GroupHoffmann-La Roche; CephalonCompleted
-
TheraOpAstraZenecaActive, not recruitingStage III Non-small Cell Lung Cancer | Locally Advanced | UnresectableSwitzerland
-
First Affiliated Hospital Xi'an Jiaotong UniversityRecruiting
-
Shanghai Jiao Tong University School of MedicineRecruiting
-
Fudan UniversityRecruitingHER2 Positive Early Breast CancerChina
-
AstraZenecaDaiichi SankyoActive, not recruitingBreast Cancer | Breast Neoplasms | HER2-positive Early Breast CancerUnited States, Italy, Spain, Poland, Taiwan, Thailand, Canada, Germany, Korea, Republic of, Brazil, India, Japan, Peru, Philippines, China, Saudi Arabia, Russian Federation, Bulgaria
-
AstraZenecaActive, not recruitingER+ HER2- Advanced Breast CancerUnited States, Spain, United Kingdom
-
Dantari, Inc.CompletedHER2-negative Metastatic Breast CancerUnited States